STOCK TITAN
  1. Home
  2. Sec-filings
  3. SI
  4. [8-K] SHOULDER INNOVATIONS, INC. Reports Material Event

Shoulder Innovations (NYSE: SI) promotes Jon Osborne to Chief Commercial Officer

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Shoulder Innovations, Inc., a commercial-stage medical technology company focused on the shoulder surgical care market, has promoted Jon Osborne to Chief Commercial Officer, effective August 6, 2026. He previously served as Vice President of Commercial Development and will now oversee all elements of the company’s commercial organization.

Osborne will work closely with the Customer Experience and Medical Education team to execute the company’s commercial strategy, emphasizing scaling the organization, deepening surgeon and partner relationships, and aligning commercial execution with the company’s innovation efforts. The company highlights his extensive orthopedic industry background and prior leadership roles at Smith & Nephew and other medical device firms.

Positive

  • None.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Effective date of promotion August 6, 2026 Date Jon Osborne’s role as Chief Commercial Officer became effective
Announcement date August 10, 2026 Date the company announced the promotion in a press release
Tenure at Smith & Nephew 2014 to 2023 Period Jon Osborne held multiple leadership roles at Smith & Nephew Inc.
Industry experience span 1998 to 2014 Years Osborne worked at ArthroCare, Tornier USA, and Team Surgical, Inc.
Chief Commercial Officer financial
"announced the promotion of Jon Osborne to Chief Commercial Officer"
A chief commercial officer (CCO) is the senior executive responsible for a company’s revenue-generating activities, including sales, marketing, pricing, customer relationships and business development. Think of the CCO as the head coach who builds the game plan to win customers and grow sales; their effectiveness affects how fast a company earns money, enters new markets and sustains profits, making the role a key signal for investors about future revenue and competitive strength.
commercial-stage medical technology company medical
"Shoulder Innovations, Inc. ... a commercial-stage medical technology company"
shoulder arthroplasty medical
"advanced implant systems for shoulder arthroplasty"
enabling technologies technical
"ecosystem is also comprised of enabling technologies, efficient instrument systems"
ambulatory surgery center medical
"with additional oversight for outpatient and ambulatory surgery center initiatives"
An ambulatory surgery center is a medical facility that performs planned surgical and diagnostic procedures that let patients go home the same day instead of staying overnight in a hospital. For investors, these centers act like focused, high-volume clinics for routine surgeries: they can be lower-cost and more efficient than hospitals, generate steady revenue, and are sensitive to changes in insurance payments, reimbursement rules, and local regulation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What executive leadership change did Shoulder Innovations (SI) announce?
Shoulder Innovations promoted Jon Osborne to Chief Commercial Officer, effective August 6, 2026. He assumes responsibility for the entire commercial organization and will help execute the company’s commercial strategy in the shoulder surgical care market.

What role did Jon Osborne hold at Shoulder Innovations (SI) before becoming Chief Commercial Officer?
Before becoming Chief Commercial Officer, Jon Osborne served as Vice President of Commercial Development. In that position, he helped architect the company’s go-to-market strategy and contributed to its commercial success in the shoulder surgical care market.

What experience does Jon Osborne bring to his new role at Shoulder Innovations (SI)?
Jon Osborne brings extensive orthopedic industry experience, including roles at Smith & Nephew Inc. from 2014 to 2023. His positions there spanned commercial marketing, sales leadership, and global marketing, covering sports medicine, biologics, and capital equipment portfolios.

When did Jon Osborne’s promotion at Shoulder Innovations (SI) become effective?
Jon Osborne’s promotion to Chief Commercial Officer became effective on August 6, 2026. The company publicly announced the change in a press release dated August 10, 2026, highlighting his expanded responsibilities across the commercial organization.

What is Shoulder Innovations’ (SI) focus within the medical technology sector?
Shoulder Innovations is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. Its offering centers on advanced implant systems for shoulder arthroplasty and an ecosystem designed to improve planning, implant design, and procedural efficiency.

What responsibilities will Jon Osborne have as Chief Commercial Officer of Shoulder Innovations (SI)?
As Chief Commercial Officer, Jon Osborne will oversee all commercial functions and work with the Customer Experience and Medical Education team. His focus includes scaling the organization, strengthening surgeon and partner relationships, and aligning commercial execution with the company’s innovation pipeline.
0001699350false00016993502026-08-102026-08-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________
FORM 8-K
___________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 10, 2026
___________________________________________
SHOULDER INNOVATIONS, INC.
(Exact name of registrant as specified in its charter)
Delaware001-4277127-0538764
(State or other jurisdiction of
incorporation)		(Commission File Number)(IRS Employer
Identification No.)
1535 Steele Avenue SW, Suite B
Grand Rapids, Michigan
49507
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (616) 294-1026
Not Applicable
(Former name or former address, if changed since last report)
___________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Common Stock, $0.001 par value per shareSINew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 7.01.
Regulation FD Disclosure.
On August 10, 2026, Shoulder Innovations, Inc. (the “Company”) issued a press release announcing the appointment of Jon Osborne as Chief Commercial Officer. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information contained in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01.
Financial Statements and Exhibits.
(d)Exhibits:
99.1
Press Release of the Company, dated August 10, 2026.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
2

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 10, 2026SHOULDER INNOVATIONS, INC.
(Registrant)
/s/ Jeffrey Points
Jeffrey Points
Chief Financial Officer
3
Exhibit 99.1
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
Grand Rapids, MI – August 10, 2026 – Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. Mr. Osborne, who most recently served as Vice President of Commercial Development, will now have responsibility for all elements of Shoulder Innovations' commercial organization and will work closely with its Customer Experience and Medical Education team to execute the company’s commercial strategy.
“Jon has consistently demonstrated exceptional leadership since joining Shoulder Innovations, and this promotion reflects the impact he’s had on our rapid commercial success as a key architect of our go-to-market strategy,” said Rob Ball, CEO of Shoulder Innovations. “His depth of experience across the orthopedic industry, paired with his keen understanding of our business, strong relationships with our surgeon customers, and proven ability to execute, positions him well to lead our commercial organization as we continue to scale adoption of our broad and increasingly differentiated product portfolio.”
“We’re at an exciting point in our early journey of transforming the shoulder surgical care market for our customers and their patients, and I’m looking forward to building on the strong commercial foundation that the entire Shoulder Innovations team has worked hard to build,” said Jon Osborne. “With this expanded role, my focus will be on further scaling the organization, deepening our surgeon and partner relationships, and ensuring our commercial execution keeps pace with the strength of our innovation engine.”
Prior to joining Shoulder Innovations as Vice President of Commercial Development in September 2023, Mr. Osborne held several positions of increasing responsibility from 2014 to 2023 at Smith & Nephew Inc., most recently as Vice President of Commercial Marketing for the Sports Medicine business in the Americas. In this role, he was responsible for driving growth across a portfolio spanning joint repair, arthroscopic enabling technologies, biologics, and capital equipment, with additional oversight for outpatient and ambulatory surgery center initiatives. Earlier in his career at Smith & Nephew Inc., he also served as an Area Vice President of Sales and as Director of Global Marketing, where he launched products and built distribution across six continents.
Prior to Smith & Nephew, Mr. Osborne worked in sales management, global marketing, and general management from 1998 to 2014 in both domestic and international markets at ArthroCare Corporation, Tornier USA, and Team Surgical, Inc. Mr. Osborne received his Bachelor of Arts in Public Relations from Miami University in Oxford, Ohio, and his Master of Business Administration from the Leeds School of Business at the University of Colorado.
About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care –






preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.
Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com




Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

Press Releases

Other Documents